Sign in
Taking peopleNo phase

Looking at kidney problems in people with Wilson disease

Describes kidney involvement through full kidney checks in people with Wilson disease.

Key facts

Who runs it
Fondation Ophtalmologique Adolphe de Rothschild
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Description of Renal Involvement in Wilson's Disease
Status
Recruiting
People taking part
150 people, planned
Started
22 Jul 2026
Expected to end
Jul 2029
Type of study
Observational
Treatments tested
  • full renal workup
Record updated
1 October 2026

Who can take part

The trial is looking for people with Wilson's disease, to check how the disease affects their kidneys. Each person gets a full kidney workup.

Age
7 years and older
Sex
All sexes
Disease stage
Diagnosed Wilson's disease, with a Leipzig score ≥ 4 (a score used to confirm the diagnosis).
Earlier treatment
People who have had an organ transplant cannot join.
Main reasons for not taking part
  • Had an organ transplant
  • Known kidney disease not caused by Wilson's disease
  • Pregnant or breastfeeding women
Show the full registry criteria (5)Hide the full registry criteria

Who can take part

  • Patient aged 7 years and older
  • Diagnosed with Wilson's disease, with a Leipzig score ≥ 4

Who cannot take part

  • Patient who has undergone organ transplantation
  • Known renal comorbidity unrelated to Wilson's disease
  • Pregnant or breastfeeding woman

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Wilson disease

This trial is currently available in France.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Wilson's disease (WD) is a rare genetic disorder that leads to copper accumulation in various tissues, including the liver, nervous system, heart, and kidneys. Renal involvement in WD has been poorly studied, and systematic screening is not currently recommended.

Read full original descriptionShow less

Indirect renal complications are the most common, such as hepatorenal and cardiorenal syndromes, as well as severe complications like hemolysis or rhabdomyolysis. However, literature suggests that copper may exert a direct toxic effect on renal tubular cells, leading to both proximal and distal tubular dysfunction. These may manifest through often subtle signs, such as aminoaciduria, glycosuria, hypouricemia, and low-molecular-weight proteinuria. Electrolyte imbalances of varying severity may also occur, including hypokalemia, which can cause muscle cramps and cardiac arrhythmias, as well as acid-base disorders (proximal or distal renal tubular acidosis), and/or phosphate-calcium metabolism abnormalities (phosphate diabetes and hypercalciuria). These latter issues may lead to complications such as urinary stones, nephrocalcinosis, and even fracture-related osteoporosis.

In addition, long-term treatment with D-penicillamine (DPA), a common therapy for WD, can cause renal damage in 10-20% of cases, mainly affecting the glomeruli. This includes membranous nephropathy, severe proliferative glomerulonephritis, or nephrotic syndrome with minimal change disease.

Without appropriate monitoring and preventive care, both direct and indirect renal complications can lead to acute or chronic kidney failure. It is likely that the prevalence and systemic impact of renal involvement in WD are currently underestimated.

The group in the trial

  • Wilson disease patients

    Patients followed for wilson disease

    Treatment: full renal workup

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Description of Renal Involvement in Wilson's Disease
Plain-language title
Looking at kidney problems in people with Wilson diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07075393, who can take part
Record updated
1 October 2026